The ROE (Return on Equity) of BioNexus Gene Lab Corp (BGLC) is -19.20%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -19.20% |
| 2023-12-31 | -27.22% |
| 2022-12-31 | -5.40% |
| 2021-12-31 | 10.45% |
| 2020-12-31 | 16.37% |
| 2019-12-31 | -22.32% |
| 2018-12-31 | 1.97% |
| 2017-12-31 | -133.33% |